Price
175.94
+1.02%O:177.93
H:179.01
L:174.8
C:175.94
52W Range
168399.58
+5%/-56%
Market Cap
₹881.33 Cr
Traded: ₹0.16 Cr (0.02%) 0.0x
Free Float: ₹100.21 Cr (0.16% of FF traded)
Volume · 60D trend
9.17 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
1W:+0% 1M:-14% 3M:-23% 6M:-34% 12M:-34%
Valuation
P/E115.8
P/B13.6
P/S9.3
EV/EBIT73.0
Business Strength
ROE19.0%
ROCE16.9%
OPM26.1%
NPM12.5%
Growth (3Y CAGR)
EPS+11.6%
Sales--
Profit--
3Y Return+170.0%
Balance Sheet
Debt/Equity1.6
Debt102 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%
Cash Position
CFO/NP-409.1%
FCF-44.6 Cr
FCF 3Y Avg--
Cash/MCap--
Others
Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle748 days
Tradeable Free Float11.4%
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Current
₹ 2.05 L
0.02% FF
60d high
₹ 2.28 L
60d low
₹ 2.03 L
60d mean
₹ 2.14 L
vs mean
▼ 4.24%
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -- | -- | -57.0% | -- |
| ROE | -- | -- | -- | -- | -- | -- |
| Return | -- | +110.0% | +170.0% | +1.0% | -- | Stable |
| Profit | -- | -- | -- | -- | +11.0% | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Debt / Equity1.57
Interest Coverage-3.3x
Promoter Pledge0.0%
Borrowings102 Cr
Efficiency
Receivable Days119 days
Inventory Days682 days
Payable Days53 days
Cash Conversion cycle748 days
Cash Position
Operating Cash Flow-45 Cr
Investing Cash Flow3 Cr
Financing Cash Flow41 Cr
Free Cash Flow-45 Cr
Detailed Financials
Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | |
|---|---|---|---|---|---|
| Sales | 29 | 28 | 22 | 16 | 127 |
| Expenses | 23 | 22 | 15 | 13 | 118 |
| Operating Profit | 5 | 5 | 7 | 3 | 9 |
| OPM % | 18.2% | 19.1% | 30.5% | 19.7% | 6.9% |
| Other Income | 0 | 1 | -0 | 0 | 0 |
| Interest | 2 | 3 | 2 | 2 | 3 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 3 | 5 | 2 | 5 |
| Tax % | 24.0% | 77.7% | 22.2% | 25.0% | -0.4% |
| Net Profit | 2 | 1 | 4 | 1 | 5 |
| Exceptional Items | -0 | 0 | -0 | 0 | -0 |
| EPS (Rs) | 0.4 | 0.1 | 0.7 | 0.2 | 1.1 |
| Sales Growth (YoY) | 81.0% | -78.0% | -- | -- | -- |
| Sales Growth (QoQ) | 3.4% | 25.1% | 39.8% | -87.5% | -- |
| OP Growth (YoY) | 67.0% | -40.0% | -- | -- | -- |
| OP Growth (QoQ) | -1.3% | -21.8% | -- | -64.5% | -- |
| Profit Growth (YoY) | 115.0% | -89.0% | -- | -- | -- |
| EPS Growth (YoY) | 91.3% | -87.2% | -- | -- | -- |
| EPS Growth (QoQ) | 214.3% | -80.3% | 208.7% | -78.9% | -- |
| OP Margin | 18.2% | 19.1% | 30.5% | 19.7% | 6.9% |
| Net Margin | 7.7% | 2.5% | 16.0% | 7.4% | 4.3% |
| Material Cost % | 79.0% | 75.0% | 65.0% | 75.0% | 90.0% |
| Employee Cost % | 2.0% | 3.0% | 3.0% | 3.0% | 1.0% |
| P/S | 9.34 | -- | -- | -- | -- |
| P/E | 115.75 | -- | -- | -- | -- |
| P/B | 13.56 | -- | -- | -- | -- |